About this trial
This HTX treatment study evaluates the effects of chest tube size and the benefits of daily irrigations on acute HTX. 20 acutely injured but stable trauma patients requiring a chest tube for HTX will be enrolled. Patients will be assigned a 28Fr or 14 Fr chest tube with serial lavage and drainage. The endpoints will be HTX volume (by CT scan), complications, additional interventions, hospital length of stay, chest tube duration, provider feedback, and patient-reported outcomes.
Eligibility criteria
Qualifiers
Able to provide consent for the research study
More than 15 years of age
Presence of acute traumatic HTX or HTX-PTX diagnosed on chest CT scan within 24 hours of injury and clinical indication for drainage (hemothorax of moderate or large size greater then 300 mL)
Hemodynamic stability (heart rate 120 beats per minute; systolic blood pressure 90 mmHg)
Disqualifiers
Less than 15 years of Age
Prisoner
Pregnant due to the risk of CT scans
HTX or HTX-PTX not requiring drainage or drainage performed prior to randomization/enrollment
Trial design
Treatments tested in this trial
- CLR Irrigator
- Serial Lavage and Drainage
- 28 Fr Open Chest Tube
- Percutaneous 14Fr Chest Tube
Treatment groups
Sponsors and collaborators
University of Pennsylvania
Lead sponsor
CLR Medical
Collaborator